Dirk Zimmermann

PreComb’s high throughput and automated platform accurately predicts drug-response.

• President Exact Sciences International • Heading Business Unit International. P&L accountability for all Exact Sciences ex-US business. • Member of Executive Leadership Team of Exact Sciences • Providing oversight to Sales, Commercial Operations, Market Access, Medical Affairs, Marketing, Finance, HR, Legal, Customer Service, & Portfolio Strategy and leadership to a 400-member global workforce in EMEA, APAC, Canada, and LATAM

• Heading Business Unit with P&L-accountability for B2B Biopharma, Oncology, Infectious Diseases • Head of Corporate Business Development • Member of Executive Leadership Team of Biocartis Group

• Hilden, Manchester, Germantown, Melbourne, Marseille, Hombrechtikon, Waltham • Heading all QIAGEN departments in USA, Europe, and APAC for project management, automated systems development (LS & Dx), AND for Oncology, PHC, Infectious Diseases, and QuantiFERON. • Heading Next Generation Sequencing development and project mgmt (http://www.genereaderngs.com/). • General management of the QIAGEN sites at Manchester, UK, AND at Waltham, MA, USA. • Heading Corporate Ventures Diagnostics.

Engineering service provider in the field of qPCR, Next Generation Sequencing, and Capillary Electrophoresis

Nanopore Next Generation Sequencing

• Hilden, Manchester, Germantown, Marseille, Melbourne, Singapore, Hombrechtikon • Heading all QIAGEN departments in USA, Europe, and APAC for project management, automated systems development (Life Sciences and Diagnostics), AND for Oncology, Personalized Healthcare, Infectious Diseases, and QuantiFERON. • General management of the QIAGEN site at Manchester, UK.

• Hilden, Manchester, Germantown, Marseille, Melbourne, Singapore, Hombrechtikon • Heading all QIAGEN departments in Europe and APAC for project management, automated systems development (Life Sciences and Diagnostics), AND for Oncology, Personalized Healthcare, and Infectious Diseases. • General management of the QIAGEN site at Manchester, UK.

• Rotkreuz, Branchburg, Pleasanton • Heading product development and project management of the cobas® 6800/8800 and cobas® p 680 systems and the IVD and blood-screening assay portfolio from concept to series level (https://www.cobas68008800.com/).

Heading research group for Nanobiophysics and Nanobiotechnology